ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,517.20
      0.15%
      US Tech 100
      19,499.20
      0.10%
      Dow Jones
      39,325.39
      -0.02%
      Brent Oil
      86.435
      -0.01%
      Bitcoin
      60,462.31
      -2.52%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Dyne Therapeutics Inc (DYN)

      7. Dyne Therapeutics Inc (DYN) News

      DYN

      Dyne Therapeutics (DYN)

      Dyne Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:DYN
      DateTimeSourceHeadlineSymbolCompany
      1:00PMiHub NewswireFeaturedFreedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent
      06/02/20214:59PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DYNDyne Therapeutics Inc
      06/02/20214:05PMGlobeNewswire Inc.Dyne Therapeutics Announces Chief Scientific Officer TransitionNASDAQ:DYNDyne Therapeutics Inc
      05/26/20214:58PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DYNDyne Therapeutics Inc
      05/26/20217:30AMGlobeNewswire Inc.Dyne Therapeutics to Present at Jefferies Virtual Healthcare ConferenceNASDAQ:DYNDyne Therapeutics Inc
      05/14/20217:00AMGlobeNewswire Inc.Dyne Therapeutics Presents New Preclinical Data from its Myotonic Dystrophy Type 1 Program During American Society of Gene & ...NASDAQ:DYNDyne Therapeutics Inc
      05/06/20217:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DYNDyne Therapeutics Inc
      05/06/20217:28AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DYNDyne Therapeutics Inc
      04/27/20214:35PMGlobeNewswire Inc.New Preclinical Data from Dyne Therapeutics’ Myotonic Dystrophy Type 1 Program to be Featured in Presentations During Upcom...NASDAQ:DYNDyne Therapeutics Inc
      04/14/20214:17PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DYNDyne Therapeutics Inc
      03/04/20217:44AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DYNDyne Therapeutics Inc
      03/04/20217:37AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:DYNDyne Therapeutics Inc
      03/04/20217:35AMGlobeNewswire Inc.Dyne Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent HighlightsNASDAQ:DYNDyne Therapeutics Inc
      03/04/20217:25AMGlobeNewswire Inc.Dyne Therapeutics Appoints Wildon Farwell, M.D., MPH, as Chief Medical OfficerNASDAQ:DYNDyne Therapeutics Inc
      02/16/20215:33PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DYNDyne Therapeutics Inc
      02/16/20214:48PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DYNDyne Therapeutics Inc
      02/16/20214:36PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DYNDyne Therapeutics Inc
      02/16/20216:45AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DYNDyne Therapeutics Inc
      02/12/20214:35PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DYNDyne Therapeutics Inc
      02/08/20217:30AMGlobeNewswire Inc.Dyne Therapeutics Appoints Ashish Dugar, Ph.D., MBA, Senior Vice President, Global Head of Medical AffairsNASDAQ:DYNDyne Therapeutics Inc
      02/03/20213:13PMEdgar (US Regulatory)Schedule 13gNASDAQ:DYNDyne Therapeutics Inc
      01/20/20218:05PMGlobeNewswire Inc.Dyne Therapeutics Announces Pricing of $168 Million Public OfferingNASDAQ:DYNDyne Therapeutics Inc
      01/19/20218:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DYNDyne Therapeutics Inc
      01/19/20218:09AMEdgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:DYNDyne Therapeutics Inc
      01/10/20213:00PMGlobeNewswire Inc.Dyne Therapeutics Myotonic Dystrophy Type 1 Program Achieves Robust RNA Knock Down of Toxic Human Nuclear DMPK in Preclinical...NASDAQ:DYNDyne Therapeutics Inc
      01/05/20217:30AMGlobeNewswire Inc.Dyne Therapeutics to Present at 39th Annual J.P. Morgan Healthcare ConferenceNASDAQ:DYNDyne Therapeutics Inc
      12/09/20205:29PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DYNDyne Therapeutics Inc
      12/08/202010:17AMGlobeNewswire Inc.Cerevance Appoints David Lubner to Board of DirectorsNASDAQ:DYNDyne Therapeutics Inc
      11/09/20207:30AMGlobeNewswire Inc.Dyne Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:DYNDyne Therapeutics Inc
      11/05/20207:46AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DYNDyne Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:DYN

      Your Recent History

      BIT
      P1Z661
      NLBNPIT1Z661 20991231 11...
      COIN
      EBASEETH
      EURBASE Stablecoin
      Delayed Upgrade Clock